Suppr超能文献

初始促性腺激素水平和精子参数可区分不育男性对枸橼酸氯米芬的反应。

Initial gonadotropin levels and sperm parameters differentiate the response to clomiphene citrate in subfertile men.

作者信息

Jiang Tommy, Osadchiy Vadim, Santamaria Alvaro, Zheng Michael H, Modiri Neilufar, Sigalos John T, Regets Keith V, Mills Jesse N, Eleswarapu Sriram V

机构信息

Division of Andrology, Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

出版信息

Transl Androl Urol. 2022 Feb;11(2):116-123. doi: 10.21037/tau-21-987.

Abstract

BACKGROUND

Efficacy of clomiphene citrate (CC) in the treatment of male subfertility remains unclear, with inconsistent results in the literature and limited guidance from professional organizations. We sought to stratify the response to clomiphene in men based on their initial gonadotropins and semen parameters.

METHODS

We conducted a retrospective analysis of 234 patients from an academic center who took CC for subfertility. Patients with pre-treatment and 3 months follow-up total testosterone (TT) and semen analyses were included. Patients with previous hormone therapy, genitourinary surgery, prior success in conceiving pregnancy, or only one semen analysis were excluded. Primary outcomes were magnitudes of improvement in TT and semen parameters at 3 months. Student's -test (alpha =0.05) was used for univariate analyses; multivariable linear regression was used for multivariate analysis.

RESULTS

One hundred and thirty-seven patients met inclusion criteria. Thirty-four percent of patients experienced improvement in sperm concentration after 3 months of CC treatment, 13% decreased, and 53% showed no change. Using a pre-treatment TT cutoff of 300 ng/dL and gonadotropin thresholds of 7 miU/mL, initial TT did not affect magnitude of improvement in semen parameters, while lower initial gonadotropins showed statistical improvement across all outcomes. Multivariate analysis showed pre-treatment follicle stimulating hormone (FSH) was inversely correlated with improvement in TT [odds ratio (OR): 2.64e-05, 95% confidence interval (CI): 1.32e-09 to 5.28e-01, P=0.04] and sperm concentration (OR: 0.22, 95% CI: 5.70e-02 to 8.48e-01, P=0.03). We also provide initial gonadotropin cutoffs that suggest statistical benefit from CC use.

CONCLUSIONS

Men with lower gonadotropin levels may expect greater degree of improvement in both hormone and semen parameters with use of CC. Men with azoospermia do not benefit based on semen analyses alone. Degree of non-azoospermia does not affect magnitude of improvement. CC had decreasing efficacy at higher initial gonadotropin levels. These data may provide guidance in stratifying and counseling men for CC treatment.

摘要

背景

枸橼酸氯米芬(CC)治疗男性生育力低下的疗效仍不明确,文献结果不一致,专业组织的指导有限。我们试图根据男性最初的促性腺激素和精液参数对其对氯米芬的反应进行分层。

方法

我们对一家学术中心的234例因生育力低下服用CC的患者进行了回顾性分析。纳入治疗前及随访3个月时总睾酮(TT)和精液分析的患者。排除既往接受过激素治疗、泌尿生殖系统手术、既往有妊娠成功史或仅进行过一次精液分析的患者。主要结局是3个月时TT和精液参数的改善幅度。单因素分析采用Student's -检验(α =0.05);多因素分析采用多变量线性回归。

结果

137例患者符合纳入标准。CC治疗3个月后,34%的患者精子浓度有所改善,13%下降,53%无变化。以治疗前TT阈值300 ng/dL和促性腺激素阈值7 miU/mL为标准,初始TT不影响精液参数的改善幅度,而较低的初始促性腺激素水平在所有结局中均显示出统计学上的改善。多因素分析显示,治疗前促卵泡激素(FSH)与TT改善呈负相关[比值比(OR):2.64e - 05,95%置信区间(CI):1.32e - 09至5.28e - 01,P =0.04],与精子浓度改善呈负相关(OR:0.22,95% CI:5.70e - 02至8.48e - 01,P =0.03)。我们还提供了初始促性腺激素阈值,表明使用CC有统计学益处。

结论

促性腺激素水平较低的男性使用CC后,激素和精液参数可能有更大程度的改善。仅根据精液分析,无精子症男性无获益。非无精子症的程度不影响改善幅度。初始促性腺激素水平较高时,CC的疗效降低。这些数据可为男性CC治疗的分层和咨询提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ad/8899152/d36457c024d6/tau-11-02-116-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验